Anti-endothelial cells antibodies have been detected in numerous autoimmune and inflammatory diseases, including systemic lupus erythematous, rheumatoid arthritis, vasculitis and sarcoidosis. Anti-endothelial cells antibodies bind to endothelial cell antigens and induce endothelial damage. Their effects on the endothelial cell have been considered responsible, at least in part, by the vascular injury which occurs in these pathological conditions.
Meroni P., Ronda N., Raschi E., Borghi MOHumoral autoimmunity against endothelium: theory or reality?Trends Immunol2005; 5: 275-281.
2.
Cines DB, Lyss A., Reeber M., Bina M., DeHoratius RJPresence of complement-fixing anti-endothelial cell antibodies in systemic lupus erythematosus. Arthritis Rheum1984; 73: 611-625.
Ronda N., Haury M., Nobrega A., Kaveri SV, Coutinho A., Kazatchkine MDAnalysis of natural and disease-associated autoantibody repertoires: anti-endothelial cell IgG autoantibody activity in the serum of healthy individuals and patients with systemic lupus erythematosus. Int Immunol1994; 6: 1651-1660.
5.
Youinou P., Meroni PL, Khamashta MA, Shoenfeld Y.A need for standardization of the anti-endothelial-cell antibody test . Immunol Today1995; 16: 363-364.
6.
Youinou P., Le Dantec C., Bendaoud B., Renaudineau Y., Pers JO, Jamin C.Endothelium, a target for immune-mediated assault in connective tissue disease . Autoimmun Rev2006; 5: 222-228.
7.
Lutz HU, Bussolino F., Flepp R., et al. Naturally occurring anti-band-3 antibodies and complement together mediate phagocytosis of oxidatively stressed human erythrocytes. Proc Natl Acad Sci USA1987; 84: 7368-7372.
8.
Basta M., Langlois PF, Marques M., Frank MM, Fries LFHigh-dose intravenous immunoglobulin modifies complement-mediated in vivo clearance. Blood1989; 74: 326-333.
Koenig DW, Barley-Maloney L., Daniel TOA Western blot assay detects autoantibodies to cryptic endothelial antigens in thrombotic microangiopathies. J Clin Immunol1993; 13: 204-211.
11.
Naniwa T., Sugiura Y., Banno S., Yoshinouchi T., Matsumoto Y., Ueda R.Ribosomal P protein P0 as a candidate for the target antigen of anti-endothelial cell antibodies in mixed connective tissue disease. Clin Exp Rheumatol2007; 25: 593-598.
12.
Sebastian JK , Mahr AD, Ahmed SS, et al. Antiendothelial cell antibodies in patients with Wegener’s granulomatosis: Prevalence and correlation with disease activity and manifestations. J Rheumatol2007; 34: 1027-1031.
13.
Varagunam M. , Nwosu Z., Adu D., et al. Little evidence for antiendothelial cell antibodies in microscopic polyarteritis and Wegener’s granulomatosis . Nephrol Dial Transplant1993; 8: 113-117.
14.
Holmen C., Christensson M., Pettersson E., et al. Wegener’s granulomatosis is associated with organ-specific antiendothelial cell antibodies. Kidney Int2004; 66: 1049-1060.
15.
Holmen C., Elsheikh E., Stenvinkel P., et al. Circulating inflammatory endothelial cells contribute to endothelial progenitor cell dysfunction in patients with vasculitis and kidney involvement . J Am Soc Nephrol2005; 16: 3110-3120.
16.
Salmi M., Jalkanen S.Cell-surface enzymes in control of leukocyte trafficking. Nat Rev Immunol2005; 5: 760-771.
17.
Salmi M., Kalimo K., Jalkanen S.Induction and function of vascular adhesion protein-1 at sites of inflammation . J Exp Med1993; 178: 2255-2260.
18.
Wu J., Groh V., Spies T.T cell antigen receptor engagement and specificity in the recognition of stress-inducible MHC class I-related chains by human epithelial gamma delta T cells. J Immunol2002; 169: 1236-1240.
19.
Groh V., Rhinehart R., Randolph-Habecker J., Topp MS, Riddell SR, Spies T.Costimulation of CD8alphabeta T cells by NKG2D via engagement by MIC induced on virus-infected cells. Nat Immunol2001; 2: 255-260.
20.
Snyder MR, Weyand CM, Goronzy JJThe double life of NK receptors: Stimulation or co-stimulation?Trends Immunol2004; 25: 25-32.
21.
Holmen C., Elsheikh E., Christensson M., et al. Anti-endothelial cell autoantibodies selectively activate SAPK/JNK signalling in Wegener’s granulomatosis. J Am Soc Nephrol2007; 18: 2497-2508.
22.
Meroni PL, Khamashta MA, Youinou P., Shoenfeld Y.Mosaic of anti-endothelial antibodies. Review of the first international workshop on anti-endothelial antibodies: clinical and pathological significance Milan, 9 November 1994. Lupus1995; 4: 95-99.
23.
Chan TM, Frampton G., Jayne DR, et al. Clinical significance of anti-endothelial cell antibodies in systemic vasculitis: a longitudinal study comparing anti-endothelial cell antibodies and anti-neutrophil cytoplasm antibodies. Am J Kidney Dis1993; 22: 387-392.
24.
Navarro M., Cervera R., Font J., et al. Anti-endothelial cell antibodies in systemic autoimmune diseases: prevalence and clinical significance. Lupus1997; 6: 521-526.
25.
Bootsma H., Spronk PE, Ter Borg EJ, et al. The predictive value of fluctuations in IgM and IgG class anti-dsDNA antibodies for relapses in systemic lupus erythematosus. A prospective long-term observation. Ann Rheum Dis1997; 56: 661-666.
26.
Hill MB, Phipps JL, Milford-Ward A., et al. Further characterization of anti-endothelial cell antibodies in systemic lupus erythematosus by controlled immunoblotting. Br J Rheumatol1996; 35: 1231-1238.
27.
Perry GJ, Elston T., Khouri NA, et al. Antiendothelial cell antibodies in lupus: correlations with renal injury and circulating markers of endothelial damage. Q J Med1993; 86: 727-734.
28.
Bordron A., Revelen R., D’arbonneau F., et al. Functional heterogeneity of anti-endothelial cell antibodies . Clin Exp Immunol2001; 124: 492-501.
29.
Del Papa ND , Raschi E., Moroni G., et al. Anti-endothelial cell IgG fractions from systemic lupus erythematosus patients bind to human endothelial cells and induce a pro-adhesive and a proinflammatory phenotype in vitro. Lupus1999; 8: 423-429.
30.
Read MA, Whitley MZ, Gupta S., et al. Tumor necrosis factor alpha-induced E-selectin expression is activated by the nuclear factor kappa B and the c-JUN N-terminal kinase/p38 mitogen activated protein kinase pathways. J Biol Chem1997; 272: 2753-2761.
31.
Roubey RAS.Immunology of the antiphospholipid antibody syndrome. Arthritis Rheum1996; 39: 1444-1454.
32.
Hunt JE, Krilis SAThe fifth domain of beta2-glycoprotein contains a phospholipids binding site (Cys 281-Cys 288) and a region recognized by anticardiolipin antibodies . J Immunol1994; 152: 653-659.
33.
Matsuura E. , Igarashi Y., Yasuda T., Triplett DA, Koike T.Anticardiolipin antibodies recognize beta2-glycoprotein I structure altered by interacting with an oxygen modified solid phase surface . J Exp Med1994; 179: 457-462.
34.
Bordron A., Dueymes M., Levy Y., et al. Anti-endothelial cell antibody binding makes negatively charged phospholipids accessible to antiphospholipid antibodies. Arthritis Rheum1998; 41: 1738-1747.
35.
George J., Blank M., Levy Y., et al. Differential effects of anti-βglycoprotein I antibodies on endothelial cells and on the manifestations of experimental antiphospholipid syndrome. Circulation1998; 97: 900-906.
36.
Patton WA II , Granzow CA, Getts LA, et al. Identification of a heparin-binding protein using monoclonal antibodies that block heparin binding to porcine aortic endothelial cells. Biochem J1995; 311: 461-469.
37.
Shibata S., Harpel PC, Gharavi A., Rand J., Fillit H.Autoantibodies to heparin from patients with antiphospholipid antibody syndrome inhibit formation of antithrombin III-thrombin complexes. Blood1994; 83: 2532-2540.
38.
Renaudineau Y. , Revelen R., Levy Y., Gilburd B., Shoenfeld Y., Youinou P.Anti-endothelial cell antibodies in systemic sclerosis. Clin Dia Lab Immunol1999; 6: 150-160.
39.
Bordron A., Dueymes M., Levy Y., et al. The binding of some human antiendothelial cell antibodies induces endothelial cell apoptosis. J Clin Invest1998; 101: 2029-2035.
40.
Sgonc R., Gruschwitz MS, Dietrich H., Recheis H., Gershwin ME, Wick G.Endothelial cell apoptosis is a primary pathogenetic event underlying skin lesions in avian and human scleroderma. J Clin Invest1996; 98: 785-792.
41.
Sgonc R., Gruschwitz MS, Boeck G., Sepp N., Gruber J., Wick G.Endothelial cell apoptosis in systemic sclerosis is induced by antibody-dependent cellmediated cytotoxicity via CD95. Arthritis Rheum2000; 43: 2550-2562.
42.
Worda M., Sgonc R., Dietrich H., et al. In vivo analysis of the apoptosis-inducing effect of anti-endothelial cell antibodies in systemic sclerosis by the chorionallantoic membrane assay . Arthritis Rheum2003; 48: 2605-2614.
43.
Le Tonqueze M., Dueymes M., Giovangrandi Y., et al. The relationship of anti-endothelial cell antibodies to antiphospholipid antibodies in patients with giant cell arteritis and/or polymyalgia rheumatica. Autoimmunity1995; 20: 59-66.
44.
Salojin KV, Le Tonquèze M., Saraux A., et al. Antiendothelial cell antibodies: useful markers of systemic sclerosis. Am J Med1997; 102: 178-185.
45.
Negi VS, Tripathy NK, Misra R., Nityanand S.Antiendothelial cell antibodies in scleroderma correlate with severe digital ischemia and pulmonary arterial hypertension. J Rheumatol1998; 25: 462-466.
46.
Dueymes M., Levy Y., Ziporen L., et al. Do some antiphospholipid antibodies target endothelial cells ? Ann Med Interne1996; 147(Suppl 1): 22-23.
47.
Aydintug AO , Tokgoz G., D’Cruz DP, et al. Antibodies to endothelial cells in patients with Behçet’s disease. Clin Immunol Immunopathol1993; 67: 157-162.
48.
Souza RC, Lage L., Schainberg-Goldenstein C., Macedo AR, Carrasco S., Gonçalves CRAnti-endothelial cell antibodies and central nervous system involvement in Behçet’s disease. Clinics2007 ; 62: 685-690.
49.
Pivetti-Pezzi P., Priori R., Catarinelli G., et al. Markers of vascular injury in Behçet’s disease associated with retinal vasculitis . Ann Ophthamol1992; 24: 411-414.
50.
Sharief MK, Hentges R., Thomas E.Significance of CSF immunoglobulins in monitoring neurologic disease activity in Behçet’s disease. Neurology1991; 41: 1398-1401.
51.
Statement on sarcoidosis. (1999). Joint Statement of the American Thoracic Society (ATS), the European Respiratory Society (ERS) and the World Association of Sarcoidosis and Other Granulomatous Disorders (WASOG) adopted by the ATS Board of Directors and by the ERS Executive Committee, February 1999. Am J Respir Crit Care Med 1999; 160: 736-755.
52.
Inui N., Matsui T., Suda T., Childa K.Anti-endothelial cell antibodies in patients with sarcoidosis. Chest2008; 133: 955-960.
53.
Takabatake N., Arao T., Sata M., et al. Involvement of pulmonary endothelial cell injury in the pathogenesis of pulmonary fibrosis. A clinical assessment by 123I MIBG lung scintigraphy. Eur J Nucl Med Mol Imaging2005; 30: 221-228.
54.
American Thoracic Society / European Respiratory Society International Multidisciplinary Consensus. (2002 ). Classification of the idiopathic interstitial pneumonias . Am J Respir Crit Care Med2002; 165: 277-304.
55.
D’Cruz D., Keser G., Khamashta MA, et al. Antiendothelial cell antibodies in inflammatory myopathies: distribution among clinical and serologic groups and association with interstitial lung disease. J Rheumatol2000; 27: 161-164.
56.
Ihn H., Sato S., Fujimoto M., et al. Characterization of autoantibodies to endothelial cells in systemic sclerosis (SSc): association with pulmonary fibrosis. Clin Exp Immunol2000; 119: 203-209.
57.
Matsui T., Inui N., Suda T., Chida K.Anti-endothelial cell antibodies in patients with interstitial lung diseases . Respiratory Med2008; 102: 128-133.
